Table 4 Association of comorbidities with all-cause mortality in Type 2 DM patients
Variables | Crude HR and 95% CI | p-value | Model 1a Adjusted HR and 95% CI | p-value | Model 2b Adjusted HR and 95% CI | p-value |
|---|---|---|---|---|---|---|
Diabetic neuropathy, yes | 0.58 (0.56–0.6) | < 0.001 | 0.76 (0.74–0.79) | < 0.001 | 0.81 (0.77–0.85) | < 0.001 |
Coronary artery disease, yes | 0.78 (0.77–0.8) | < 0.001 | 0.85 (0.84–0.87) | < 0.001 | 1.04 (1.02–1.07) | < 0.001 |
Hypertension, yes | 0.56 (0.55–0.57) | < 0.001 | 0.58 (0.57–0.59) | < 0.001 | 0.54 (0.53–0.55) | < 0.001 |
Diabetic nephropathy, yes | 1.26 (1.21–1.32) | < 0.001 | 1.63 (1.56–1.71) | < 0.001 | 2.06 (1.96–2.16) | < 0.001 |
Retinopathy, yes | 0.53 (0.51–0.56) | < 0.001 | 0.72 (0.69–0.76) | < 0.001 | 0.72 (0.68–0.77) | < 0.001 |
Stroke, yes | 1.5 (1.45–1.56) | < 0.001 | 1.56 (1.51–1.62) | < 0.001 | 1.8 (1.73–1.87) | < 0.001 |
Diabetic foot, yes | 1.13 (1.1–1.18) | < 0.001 | 1.32 (1.27–1.36) | < 0.001 | 1.23 (1.18–1.28) | < 0.001 |
Amputations, yes | 1.79 (1.69–1.88) | < 0.001 | 1.95 (1.85–2.05) | < 0.001 | 1.64 (1.54–1.75) | < 0.001 |
Neoplasms, yes | 1.31 (1.28–1.35) | < 0.001 | 1.3 (1.27–1.34) | < 0.001 | 1.37 (1.34–1.41) | < 0.001 |